Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Vicore Pharma Holding AB

Closing information (x1000 NOK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 112,768 Less Arrow 0 Equal arrow 0
Financial expenses 8 More Arrow 363 More Arrow 450
Earnings before taxes -174,176 Less Arrow -315,383 More Arrow -273,185
EBITDA -197,953 Less Arrow -322,296 More Arrow -271,825
Total assets 1,240,762 Less Arrow 504,326 Less Arrow 319,725
Current assets 1,240,762 Less Arrow 502,053 Less Arrow 255,198
Current liabilities 75,190 Less Arrow 39,286 More Arrow 43,788
Equity capital 1,164,674 Less Arrow 461,324 Less Arrow 273,447
- share capital 120,961 Less Arrow 56,589 Less Arrow 38,711
Employees (average) 27 Less Arrow 25 Less Arrow 21

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 93.9% Less Arrow 91.5% Less Arrow 85.5%
Turnover per employee 4,177 Less Arrow 0 Equal arrow 0
Profit as a percentage of turnover -154.5%
Return on assets (ROA) -14.0% Less Arrow -62.5% Less Arrow -85.3%
Current ratio 1650.2% Less Arrow 1277.9% Less Arrow 582.8%
Return on equity (ROE) -15.0% Less Arrow -68.4% Less Arrow -99.9%
Change turnover 112,768 Less Arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 2 More Arrow 4 More Arrow 5
Chg. No. of employees % 8% More Arrow 19% More Arrow 31%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.